Promethean BioPharma Limited has finalised the acquisition of Tcann Pty Ltd setting the stage for the execution of it's growth strategy.
Sale of TCann to Promethean
Updated: Apr 20
top of page
Search
Recent Posts
See AllA world-first cannabis pill is being trialled that could bring relief to millions of people living with chronic pain. If successful,...
In a groundbreaking initiative, Australia is set to lead the world in the development of a revolutionary cannabis pill designed to bring...
Promethean BioPharma joins over-the-counter CBD race to register a Schedule 3, over-the-counter CBD medicine with a clinical trial of...
bottom of page
Comments